That is, there is a variety of other cooperating mutations in other cellular pathways, e.g., in proteins such as NOTCH, BCL6, IRF4, p300/CBP, that cluster with NF-κB pathway mutations to define further distinct genetic subtypes of DLBCL [18]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.